Diagnostic assay and technology advancement for detecting SARS-CoV-2 infections causing the COVID-19 pandemic

[1] Zhu N(2020)A novel coronavirus from patients with pneumonia in China, 2019 N Engl J Med. 5 536-544

[2] Zhang D(2020)Severe acute respiratory syndrome-related coronavirus: the species and its viruses—a statement of the Coronavirus Study Group Nat Microbiol. 72 e415-9

[3] Wang W(2021)Why contact tracing efforts have failed to curb coronavirus disease 2019 (COVID-19) transmission in much of the United States Clin Infect Dis. 22 231-5

[4] Li X(2020)Current development of COVID-19 diagnostics, vaccines and therapeutics Microbes Infect. 70 2129-2132

[5] Yang B(2015)IFN-α2a or IFN-β1a in combination with ribavirin to treat Middle East respiratory syndrome coronavirus pneumonia: a retrospective study J Antimicrob Chemother 58 e01695-20

[6] Song J(2020)Challenges and controversies to testing for COVID-19 J Clin Microbiol. 15 112766-83

[7] Zhao X(2021)opvCRISPR: one-pot visual RT-LAMP-CRISPR platform for SARS-cov-2 detection Biosens Bioelectron. 19 171-4

[8] Huang B(2021)Considerations for diagnostic COVID-19 tests Nat Rev Microbiol. 11 1-761

[9] Shi W(2020)Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV Nat Commun. 13 752-4

[10] Lu R(2013)Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study Lancet Infect Dis. 9 231-2

[1] Zhu N(2020)A novel coronavirus from patients with pneumonia in China, 2019 N Engl J Med. 5 536-544

[2] Zhang D(2020)Severe acute respiratory syndrome-related coronavirus: the species and its viruses—a statement of the Coronavirus Study Group Nat Microbiol. 72 e415-9

[3] Wang W(2021)Why contact tracing efforts have failed to curb coronavirus disease 2019 (COVID-19) transmission in much of the United States Clin Infect Dis. 22 231-5

[4] Li X(2020)Current development of COVID-19 diagnostics, vaccines and therapeutics Microbes Infect. 70 2129-2132

[5] Yang B(2015)IFN-α2a or IFN-β1a in combination with ribavirin to treat Middle East respiratory syndrome coronavirus pneumonia: a retrospective study J Antimicrob Chemother 58 e01695-20

[6] Song J(2020)Challenges and controversies to testing for COVID-19 J Clin Microbiol. 15 112766-83

[7] Zhao X(2021)opvCRISPR: one-pot visual RT-LAMP-CRISPR platform for SARS-cov-2 detection Biosens Bioelectron. 19 171-4

[8] Huang B(2021)Considerations for diagnostic COVID-19 tests Nat Rev Microbiol. 11 1-761

[9] Shi W(2020)Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV Nat Commun. 13 752-4

[10] Lu R(2013)Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study Lancet Infect Dis. 9 231-2